A basic study using immunodeficient mice engrafted by human arteries and reconstituted with T cells from GCA patients demonstrated that tofacitinib effectively suppressed tissue-resident memory T cells with decreasing IFN-γ and IL-17 (19). The gene discussed is IFNG; the disease is temporal arteritis.